Scribble

MRNA Stock Quote Price and Forecast | CNN

MRNA

Moderna, Inc.

Key terms

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Sector

Industry

Employees

Founded

Website

Key stock statistics

1-day range

52-week range

Market cap

P/E ratio

Next earnings date

Dividend yield

Ex-dividend date

Dividend pay date

Key terms

Smart score

May 06 1:55am ET Maintaining Hold on Moderna: Balancing Strong Q1 Sales with Future Uncertainties and Pipeline Progress by TipRanks May 03 9:46am ET Moderna price target raised to $135 from $125 at RBC Capital by TipRanks May 03 9:28am ET Moderna price target raised to $155 from $125 at Jefferies by TipRanks May 03 8:45am ET Moderna price target raised to $106 from $91 at Canaccord by TipRanks May 03 8:32am ET Moderna price target raised to $163 from $142 at Oppenheimer by TipRanks May 03 8:23am ET Analysts Are Bullish on These Healthcare Stocks: Elevation Oncology (ELEV), Moderna (MRNA) by TipRanks May 03 7:04am ET RBC Capital Remains a Buy on Moderna (MRNA) by TipRanks May 02 1:15pm ET Moderna’s Hold Rating Maintained Amidst Positive Sales Outlook and Awaited RSV Vaccine Launch by TipRanks May 02 9:40am ET Unusually active option classes on open May 2nd by TipRanks May 02 8:14am ET MRNA Earnings: Moderna Reports Mixed Results in Q1 by TipRanks May 02 7:47am ET Metagenomi price target lowered to $17 from $21 at ChardanModerna by TipRanks May 02 7:05am ET Options Volatility and Implied Earnings Moves Today, May 02, 2024 by TipRanks May 02 6:39am ET Moderna: 2024 expectations remain consistent with prior expectations by TipRanks May 02 6:37am ET Moderna reaffirms 2024 product sales outlook by TipRanks May 02 6:36am ET Moderna sees initial regulatory approvals of RSV vaccine in 1H24 by TipRanks May 02 6:35am ET Moderna reports Q1 EPS ($3.07), consensus ($3.35) by TipRanks May 02 5:21am ET Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Moderna (MRNA) and Neurocrine (NBIX) by TipRanks May 02 4:52am ET Metagenomi downgraded to Neutral from Overweight at JPMorgan by TipRanks May 01 8:25pm ET Notable companies reporting before tomorrow’s open by TipRanks May 01 1:55pm ET Notable companies reporting before tomorrow’s open by TipRanks Apr 30 7:40am ET Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), Moderna (MRNA) and Ionis Pharmaceuticals (IONS) by TipRanks Apr 26 12:45pm ET Cantor Fitzgerald biopharma analyst holds analyst/industry conference call by TipRanks Apr 26 4:55am ET Cantor Fitzgerald biopharma analyst holds analyst/industry conference call by TipRanks Apr 24 8:46am ET Moderna, OpenAI collaborate to advance mRNA medicine by TipRanks Apr 22 7:28am ET Moderna announces contract with Brazil to supply 12.5M Covid-19 vaccines by TipRanks Apr 17 2:00pm ET Cantor Fitzgerald biopharma analyst holds analyst/industry conference call by TipRanks Apr 15 5:48am ET Novavax (NASDAQ:NVAX) Jumps Amid Activist Investor Push by TipRanks Apr 12 11:08am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 11 11:59am ET Moderna (NASDAQ:MRNA) Postpones Plans of Vaccine Plant in Kenya by TipRanks Apr 11 6:34am ET Moderna pauses efforts to build vaccine plant in Kenya, FT says by TipRanks Apr 09 1:32pm ET Moderna’s (NASDAQ:MRNA) Latest Treatment Line Gives Shares New Life by TipRanks

May 02 6:30am ET Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates by Accesswire Apr 25 7:00am ET Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress by Accesswire Apr 24 8:00am ET Moderna and OpenAI Collaborate To Advance mRNA Medicine by Accesswire Apr 17 7:00am ET Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024 by Accesswire Apr 03 11:00am ET Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature by Accesswire Mar 27 6:30am ET Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials by Accesswire Mar 26 7:00am ET Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine by Accesswire

1-year income & revenue

Key terms

analyst rating

buy
hold
sell

1-year stock price forecast

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Scaffolding and construction netting near an apartment building in New York, US, on Wednesday, Oct. 11, 2023. Monthly fees and expenses for inspections, insurance and climate-friendly upgrades are squeezing residents of the city's many co-op and condo buildings. Photographer: Michael Nagle/Bloomberg

Michael Nagle/Bloomberg/Getty Images

For US renters, the chance of owning a home is going from bad to worse

Close-up detail of the Disney+ app icon on an Apple iPhone 12 Pro smartphone screen, on November 11, 2020. (Photo by Phil Barker/Future Publishing via Getty Images)

Phil Barker/Future Publishing/Getty Images

Disney just had its worst day in a year and a half

People shop in a supermarket in the Manhattan borough of New York city on January 27, 2024. (Photo by Charly TRIBALLEAU / AFP) (Photo by CHARLY TRIBALLEAU/AFP via Getty Images)

Charly Triballeau/AFP/Getty Images

Americans have spent their savings. Economists worry about what comes next

Berkshire Hathaway Chairman Warren Buffett walks through the exhibit hall as shareholders gather to hear from the billionaire investor at Berkshire Hathaway Inc's annual shareholder meeting in Omaha, Nebraska, on May 4, 2019.

Scott Morgan/Reuters/File

Warren Buffett compares AI to nuclear weapons in stark warning